Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 200 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact200 DOIs

Add abstracts to 143 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact143 DOIs

Deposit reference lists for 114 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact114 DOIs

DOIs for this ISSN

Showing the top 5 of 909 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Nanoparticles in the clinic (10.1002/btm2.10003)	ORCID	77.00	1201
2	BioTM Buzz (Volume 4, Issue 1) (10.1002/btm2.10125)	Abstract ORCID	73.12	28
3	Issue Information – Table of Contents (10.1002/btm2.10100)	Abstract References ORCID	71.57	8
4	Gelatin‐polysaccharide composite scaffolds for 3D cell cultu… (10.1002/btm2.10124)	ORCID	64.21	369
5	Virus‐like particles: Next‐generation nanoparticles for targ… (10.1002/btm2.10049)	ORCID	62.70	321
6	Applications of decellularized extracellular matrix in bone… (10.1002/btm2.10110)	ORCID	62.14	305
7	ROS‐responsive drug delivery systems (10.1002/btm2.10014)	ORCID	59.95	249
8	Evolving trends in mAb production processes (10.1002/btm2.10061)	ORCID	58.95	227
9	Microfluidics‐based 3D cell culture models: Utility in novel… (10.1002/btm2.10013)	ORCID	58.06	209
10	Designing biomaterials with immunomodulatory properties for… (10.1002/btm2.10063)	ORCID	57.31	195
11	Ionic liquids for addressing unmet needs in healthcare (10.1002/btm2.10083)	ORCID	55.70	168
12	Biomimetic strategies for targeted nanoparticle delivery (10.1002/btm2.10004)	ORCID	54.55	151
13	Peptide‐based supramolecular hydrogels for delivery of biolo… (10.1002/btm2.10041)	ORCID	53.73	140
14	A microfluidic model of human brain (μHuB) for assessment of… (10.1002/btm2.10126)	ORCID	50.22	101
15	Stimuli‐responsive delivery of therapeutics for diabetes tre… (10.1002/btm2.10036)	ORCID	50.11	100
16	Mechanisms of light‐induced liposome permeabilization (10.1002/btm2.10032)	ORCID	49.21	92
17	Intestinal mucoadhesive devices for oral delivery of insulin (10.1002/btm2.10015)	ORCID	48.98	90
18	Anticancer nanoparticulate polymer‐drug conjugate (10.1002/btm2.10033)	ORCID	48.86	89
19	Nanoengineered thermoresponsive magnetic hydrogels for biome… (10.1002/btm2.10034)	ORCID	48.11	83
20	Introduction to special issue on “Responsive Materials and S… (10.1002/btm2.10045)	Abstract ORCID	47.71	8
21	Lipid nanoparticles silence tumor necrosis factor α to impro… (10.1002/btm2.10123)	ORCID	47.58	79
22	Visible light crosslinkable human hair keratin hydrogels (10.1002/btm2.10077)	ORCID	47.30	77
23	Rescuing mesenchymal stem cell regenerative properties on hy… (10.1002/btm2.10104)	ORCID	46.73	73
24	Peptide delivery with poly(ethylene glycol) diacrylate micro… (10.1002/btm2.10070)	ORCID	46.43	71
25	Engineering responsive supramolecular biomaterials: Toward s… (10.1002/btm2.10031)	ORCID	45.81	67
26	Emerging applications of exosomes in cancer therapeutics and… (10.1002/btm2.10059)	ORCID	45.81	67
27	Clinical translation of microbe‐based therapies: Current cli… (10.1002/btm2.10093)	ORCID	45.15	63
28	Scalable synthesis and validation of PAMAM dendrimer‐<i>N</i… (10.1002/btm2.10094)	ORCID	44.81	61
29	Self‐healing encapsulation and controlled release of vaccine… (10.1002/btm2.10103)	ORCID	44.27	58
30	Tunable particles alter macrophage uptake based on combinato… (10.1002/btm2.10047)	ORCID	44.09	57
31	Hepatitis B vaccination using a dissolvable microneedle patc… (10.1002/btm2.10098)	ORCID	43.70	55
32	Introduction to special issue on “Nanoparticles in Medicine:… (10.1002/btm2.10012)	Abstract ORCID	42.25	6
33	How will the field of gene therapy survive its success? (10.1002/btm2.10090)	ORCID	40.32	40
34	Reducing neuroinflammation by delivery of IL‐10 encoding len… (10.1002/btm2.10018)	ORCID	40.05	39
35	Engineered heparins as new anticoagulant drugs (10.1002/btm2.10042)	ORCID	39.78	38
36	Human pluripotent stem cell‐derived epicardial progenitors c… (10.1002/btm2.10062)	ORCID	39.49	37
37	Polymeric nanoparticle‐based delivery of TRAIL DNA for cance… (10.1002/btm2.10019)	ORCID	39.21	36
38	Polymeric curcumin nanoparticles by a facile in situ method… (10.1002/btm2.10112)	ORCID	38.91	35
39	Uptake and function of membrane‐destabilizing cationic nanog… (10.1002/btm2.10120)	ORCID	38.91	35
40	Engineering of nanoparticle size via electrohydrodynamic jet… (10.1002/btm2.10010)	ORCID	37.63	31
41	Picoliter‐volume inkjet printing into planar microdevice res… (10.1002/btm2.10053)	ORCID	37.63	31
42	Microfluidic co‐culture devices to assess penetration of nan… (10.1002/btm2.10079)	ORCID	37.63	31
43	Engineering, on‐demand manufacturing, and scaling‐up of poly… (10.1002/btm2.10118)	ORCID	37.63	31
44	Role of synergy and immunostimulation in design of chemother… (10.1002/btm2.10129)	ORCID	37.63	31
45	Biodegradable bioadhesive nanoparticle incorporation of broa… (10.1002/btm2.10092)	ORCID	37.28	30
46	Multivariate learning framework for long‐term adaptation in… (10.1002/btm2.10119)	ORCID	37.28	30
47	Microneedle‐based intradermal delivery of stabilized dengue… (10.1002/btm2.10127)	ORCID	37.28	30
48	Schedule dependent synergy of gemcitabine and doxorubicin: I… (10.1002/btm2.10082)	ORCID	36.93	29
49	Dose enhancement and cytotoxicity of gold nanoparticles in c… (10.1002/btm2.10007)	ORCID	36.56	28
50	Detachment of ligands from nanoparticle surface under flow a… (10.1002/btm2.10089)	ORCID	36.56	28